André Russowsky Brunoni

Associate Professor 3 at the USP School of Medicine. Head of the Interdisciplinary Neuromodulation Service and Co-Director of the ECT Service of the HC-FMUSP Institute of Psychiatry. Member of the Innovation Committee of HC-FMUSP (INOVAHC). Full Advisor of the PPGs in Medical Sciences and Psychiatry at FMUSP. Appointed by the Web of Science / Clarivate Analytics as one of the most cited researchers in the world in the years 2019, 2020, 2021 and 2022. Prof. Brunoni has more than 365 articles published in indexed journals, with more than 15400 citations and an H index of 57 (Scopus). Prof. Brunoni has publications as 1st or last author in prominent journals such as the New England Journal of Medicine, JAMA Psychiatry, Molecular Psychiatry, Lancet Psychiatry and American Journal of Psychiatry. He has an extensive international network of collaborators, including centers at Harvard University, Oxford University, University of Munich, University of New South Wales, University of Toronto, UTHealth in Texas, Ghent University, and the University of Coimbra.Education: MBA by USP/Esalq (2021-2023). Habilitation Degree at the Department of Psychiatry at the Faculty of Medicine of USP (2017). Newton Advanced Fellowship, in partnership with Oxford University (2021-2023). Visiting Professor at the University of Munich (April-2017/October-2018) with an experienced researcher grant from CAPES / Alexander Von Humboldt Foundation. PhD in Neuroscience and Behavior at the Institute of Psychology at USP (2010-2012), with a Sandwich Doctorate at Harvard Medical School (Boston, USA). Graduation in Medicine (2004), Residencies in Internal Medicine (2005-2007) and Psychiatry (2007-2010) from the Faculty of Medicine of USP.Lines of investigation: depression and mood disorders, non-invasive neuromodulation in the treatment of mental disorders.

Professor Associado 3 da Faculdade de Medicina da USP. Chefe do Serviço Interdisciplinar de Neuromodulação e Co-Diretor do Serviço de ECT do Instituto de Psiquiatria do HC-FMUSP. Membro do Comitê de Inovação do HC-FMUSP (INOVAHC). Orientador Pleno dos PPGs de Ciências Médicas e de Psiquiatria da FMUSP. Apontado pelo Web of Science / Clarivate Analytics como um dos pesquisadores mais citados do mundo nos anos de 2019, 2020, 2021 e 2022. Possui mais de 365 artigos publicados em revistas indexadas, com mais de 15.400 citações e índice H de 57 (Scopus). Tem publicações como 1 ou último autor em periódicos de destaque, como New England Journal of Medicine, JAMA Psychiatry, Molecular Psychiatry, Lancet Psychiatry e American Journal of Psychiatry. Possui extensa rede internacional de colaboradores, destacando-se polos na Universidade de Harvard, Universidade Oxford, Universidade de Munique, Universidade de New South Wales, Universidade de Toronto, UTHealth no Texas, Universidade Ghent, e Universidade de Coimbra.Formação: MBA pela USP/Esalq (2021-2023). Livre-Docente pelo Departamento de Psiquiatria da Faculdade de Medicina da USP (2017). Newton Advanced Fellowship, com parceria com a Universidade Oxford (2021-2023). Professor visitante da Universidade de Munique (abril-2017/outubro-2018) com bolsa de pesquisador experiente da CAPES / Fundação Alexander Von Humboldt. Doutorado em Neurociências e Comportamento pelo Instituto de Psicologia da USP (2010-2012), com Doutorado Sanduíche na Harvard Medical School (Boston, EUA). Graduação em Medicina (2004), Residências em Clinica Médica (2005-2007) e Psiquiatria (2007-2010) pela Faculdade de Medicina da USP.Linhas de investigação: depressão e transtornos do humor, neuromodulação não-invasiva no tratamento dos transtornos mentais.